Transcript search / Intra-Cellular Therapies, Inc. / "Materials"

ITCI

Earnings call transcript

NASDAQ

2024 Q3

30 Oct 24

statements are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained

ITCI

Earnings call transcript

NASDAQ

2024 Q2

7 Aug 24

and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements

ITCI

Earnings call transcript

NASDAQ

2024 Q1

7 May 24

and expectations. Those statements are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from

ITCI

Earnings call transcript

NASDAQ

2023 Q4

22 Feb 24

to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking

ITCI

Earnings call transcript

NASDAQ

2023 Q2

3 Aug 23

to differ materially from those contained in the forward-looking statements. These and other risks are described in our periodic filings made